BRG.AU

30.25

-4.6%↓

LLC.AU

5.88

-3.13%↓

BRG.AU

30.25

-4.6%↓

LLC.AU

5.88

-3.13%↓

BRG.AU

30.25

-4.6%↓

LLC.AU

5.88

-3.13%↓

BRG.AU

30.25

-4.6%↓

LLC.AU

5.88

-3.13%↓

BRG.AU

30.25

-4.6%↓

LLC.AU

5.88

-3.13%↓

Search

Fisher & Paykel Healthcare Corp Ltd

Fechado

SetorImobiliário

32.26 1.96

Visão Geral

Variação de preço das ações

24h

Atual

Mín

30.4

Máximo

32.29

Indicadores-chave

By Trading Economics

Rendimento

153M

Vendas

951M

P/E

Médio do Setor

148.143

80.437

EPS

0.26

Rendimento de Dividendos

1.26

Margem de lucro

16.106

Funcionários

6,978

EBITDA

276M

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+20.89% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

1.26%

5.59%

Próximos Ganhos

28 de mai. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-3.8B

18B

Abertura anterior

30.3

Fecho anterior

32.26

Sentimento de Notícias

By Acuity

61%

39%

166 / 192 Ranking em Real estate

Fisher & Paykel Healthcare Corp Ltd Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

3 de fev. de 2025, 21:55 UTC

Conversa de Mercado

F&P Healthcare Could Make More in New Zealand to Counter Tariff Impact -- Market Talk

2 de fev. de 2025, 22:06 UTC

Conversa de Mercado

Fisher & Paykel Healthcare Slumps on Tariff Hit -- Market Talk

28 de nov. de 2024, 21:55 UTC

Conversa de Mercado

F&P Healthcare Bear Sees Limited Scope for Guidance Upgrades -- Market Talk

18 de nov. de 2024, 22:39 UTC

Conversa de Mercado

Sales Growth, Flu Season in Focus at F&P Healthcare's 1H Result -- Market Talk

2 de set. de 2024, 23:56 UTC

Conversa de Mercado

Fisher & Paykel's Growth Outlook Looks Attractive -- Market Talk

30 de mai. de 2024, 00:44 UTC

Conversa de Mercado
Ganhos

Fisher & Paykel FY 2025 Guidance Hinges on Currency -- Market Talk

29 de mai. de 2024, 23:35 UTC

Conversa de Mercado

Fisher & Paykel to Benefit From FX Tailwinds -- Market Talk

28 de mai. de 2024, 22:43 UTC

Conversa de Mercado

Fisher & Paykel Healthcare Making Progress in Improving Margins -- Market Talk

28 de mai. de 2024, 20:59 UTC

Ganhos

Fisher & Paykel Healthcare Corp. Ltd. Sees FY25 Net Profit After Tax NZ$310M to NZ$360M

28 de mai. de 2024, 20:58 UTC

Ganhos

Fisher & Paykel Healthcare Corp. Ltd. Sees FY25 Rev NZD1.9B-NZD2B

28 de mai. de 2024, 20:57 UTC

Ganhos

Fisher & Paykel Healthcare Corp. Ltd. FY24 Net Profit After Tax NZ$132.6M

28 de mai. de 2024, 20:56 UTC

Ganhos

Fisher & Paykel Healthcare Corp. Ltd. FY24 Rev NZD1.742B

24 de abr. de 2024, 02:38 UTC

Conversa de Mercado

F&P Healthcare's Prospects Brighten on Anaesthesia Opportunity -- Market Talk

Comparação entre Pares

Variação de preço

Fisher & Paykel Healthcare Corp Ltd Previsão

Preço-alvo

By TipRanks

20.89% parte superior

Previsão para 12 meses

Média 37.453 AUD  20.89%

Máximo 42.7 AUD

Mínimo 35 AUD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Fisher & Paykel Healthcare Corp Ltd - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

6 ratings

3

Comprar

1

Manter

2

Vender

Sentimento

By Acuity

166 / 192 Ranking em Imobiliário

Sentimento de Notícias

Evidência de Tendência de Baixa

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Fisher & Paykel Healthcare Corp Ltd

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.